Heme Oxygenase-1: Clinical Relevance in Ischemic Stroke

Author(s): Daniel Bereczki Jr.*, Jozsef Balla, Daniel Bereczki

Journal Name: Current Pharmaceutical Design

Volume 24 , Issue 20 , 2018

Become EABM
Become Reviewer
Call for Editor


Stroke is the second-leading cause of death and a leading cause of serious long-term disability worldwide, with an increasing global burden due to the growing and aging population. However, strict eligibility criteria for current treatment opportunities make novel therapeutic approaches desirable. Oxidative stress plays a pivotal role during cerebral ischemia, eventually leading to neuronal injury and cell death. The significant correlation between redox imbalance and ischemic stroke has led to various treatment strategies targeting the endogenous antioxidant system in order to ameliorate the adverse prognosis in patients with cerebral infarction. One of the most extensively investigated cellular defense pathway in this regard is the Nrf2-heme oxygenase-1 (HO-1) axis. In this review, our aim is to focus on the potential clinical relevance of targeting the HO-1 pathway in ischemic stroke.

Keywords: Ischemic stroke, oxidative stress, heme oxygenase-1, cerebral ischemia, cerebral infarction, antioxidant system.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 11 October, 2018
Page: [2229 - 2235]
Pages: 7
DOI: 10.2174/1381612824666180717101104
Price: $65

Article Metrics

PDF: 22